ArticleCardiovascular diabetology. Endocrinology reports2026
Association between the atherogenic index of plasma trajectory and risk of cardiovascular diseases among hypertensive patients: a prospective cohort study.
Article in Cardiovascular diabetology. Endocrinology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundCardiovascular disease (CVD) remains the leading cause of global mortality, with hypertension and dyslipidemia synergistically exacerbating the atherogenic risk. The atherogenic index of plasma (AIP), calculated as log (triglycerides/HDL-C), reflects lipid-driven atherosclerosis; however, evidence of long-term AIP trajectory patterns and their cardiovascular implications in hypertensive populations remains scarce.
methodsThis longitudinal study included 20,013 hypertensive participants (mean age: 56.8 ± 11.0 years; 81.9% male) from the Kailuan cohort, China. The AIP trajectories (2006-2010) were modeled using latent mixture modeling. Cox proportional hazards models were used to assess associations between AIP trajectories and incident CVD (2010-2020), adjusting for demographics, comorbidities, and medications.
resultsFour distinct AIP trajectories were identified: Low-stable group (n = 2,920; AIP range: -0.84 to -0.72), Moderate low-stable group (n = 11,121; AIP range: -0.14 to -0.10), Moderate high-stable group (n = 5,067; AIP range: 0.42 to 0.53), Elevated-increasing group (n = 905; AIP range: 1.12 to 1.46). Over a median of 11.9 (interquartile range 11.3-12.3) years of follow-up, 2,332 CVD events occurred. Compared with the low-stable group, participants in the elevated-increasing trajectory exhibited a 43% higher CVD risk (HR = 1.43, 95% CI:1.14-1.79; P-trend = 0.001), with significantly elevated risks of myocardial infarction (HR = 1.80, 1.09-2.51; P-trend < 0.001) and ischemic stroke (HR = 1.40, 1.08-1.80; P-trend = 0.001). Young hypertensives (< 45 years) with rising AIP trajectories demonstrated a 3.4-fold higher CVD risk (HR = 3.40, 1.03-11.16), whereas no associations were observed for hemorrhagic stroke (P-trend = 0.734).
conclusionsSustained elevation in AIP trajectories is associated with a higher risk of CVD in individuals with hypertension. Sustained maintenance of optimal AIP levels through regular monitoring, combined with blood pressure control and antihypertensive medication adherence, may reduce the CVD risk in hypertensive populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.